Stock MDKA MEDIKA D.D.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medika d.d.

Equities

MDKA

HRMDKARA0000

Pharmaceuticals

End-of-day quote Zagreb S.E.
Other stock markets
 07:00:00 2024-03-27 pm EDT 		5-day change 1st Jan Change
7,400 EUR -.--% Intraday chart for Medika d.d. -.--% +7.25%
Feb. 28 Medika d.d. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 Medika d.d. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 60.42 58.91 64.98 110.9 112.9 199.8
Enterprise Value (EV) 2 308.8 371.1 336 128.6 118.2 188
P/E ratio 1.76 x 0.81 x 0.85 x 1.09 x 0.97 x 9.95 x
Yield 33.3% 61.1% 58.7% 36.6% 41.6% -
Capitalization / Revenue 0.02 x 0.02 x 0.02 x 0.03 x 0.02 x 0.27 x
EV / Revenue 0.1 x 0.1 x 0.08 x 0.03 x 0.02 x 0.25 x
EV / EBITDA 5.36 x 3.5 x 2.82 x 1.03 x 0.81 x 7.67 x
EV / FCF -161 x -10.9 x 3.27 x 0.6 x 2.93 x 9.24 x
FCF Yield -0.62% -9.14% 30.5% 167% 34.2% 10.8%
Price to Book 0.13 x 0.12 x 0.12 x 0.17 x 0.16 x 1.82 x
Nbr of stocks (in thousands) 28.8 27.3 27.3 29 29 29
Reference price 3 2,101 2,161 2,384 3,830 3,899 6,900
Announcement Date 3/28/19 3/26/20 3/30/21 3/22/22 3/23/23 3/20/24
1EUR in Million2HRK in Million3EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,078 3,647 3,990 4,130 4,732 750.5
EBITDA 1 57.63 106 119.3 124.9 145.9 24.53
EBIT 1 42.79 93.2 105.9 110.4 130.4 22.33
Operating Margin 1.39% 2.56% 2.66% 2.67% 2.76% 2.98%
Earnings before Tax (EBT) 1 41.15 90.11 93.76 120.9 155.5 24.37
Net income 1 33.68 72.87 76.87 99.51 116.7 20.08
Net margin 1.09% 2% 1.93% 2.41% 2.47% 2.68%
EPS 2 1,193 2,674 2,821 3,525 4,032 693.5
Free Cash Flow 1 -1.914 -33.93 102.6 215.1 40.39 20.35
FCF margin -0.06% -0.93% 2.57% 5.21% 0.85% 2.71%
FCF Conversion (EBITDA) - - 86% 172.15% 27.69% 82.97%
FCF Conversion (Net income) - - 133.47% 216.13% 34.59% 101.35%
Dividend per Share 2 700.0 1,320 1,400 1,400 1,621 -
Announcement Date 3/28/19 3/26/20 3/30/21 3/22/22 3/23/23 3/20/24
1HRK in Million2HRK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 248 312 271 17.7 5.31 -
Net Cash position 1 - - - - - 11.8
Leverage (Debt/EBITDA) 4.309 x 2.946 x 2.272 x 0.1416 x 0.0364 x -
Free Cash Flow 1 -1.91 -33.9 103 215 40.4 20.4
ROE (net income / shareholders' equity) 7.57% 15.3% 14.6% 16.8% 17.2% 19.6%
ROA (Net income/ Total Assets) 1.32% 2.69% 2.68% 2.8% 3.03% 3.28%
Assets 1 2,543 2,709 2,864 3,549 3,858 612.3
Book Value Per Share 2 16,545 18,516 20,016 22,067 24,816 3,788
Cash Flow per Share 2 1,049 1,960 2,879 2,939 14,098 359.0
Capex 1 7.43 13.8 10.1 63.7 13.5 2.37
Capex / Sales 0.24% 0.38% 0.25% 1.54% 0.29% 0.32%
Announcement Date 3/28/19 3/26/20 3/30/21 3/22/22 3/23/23 3/20/24
1HRK in Million2HRK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
MEDIKA D.D. Stock Medika d.d.
+7.25% 229M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. MDKA Stock
  4. Financials Medika d.d.